Technical Updates, Appointments, and Redemption of Debentures - Research Reports on Macy’s, McKesson, Best Buy, United Continental and Pandora

NEW YORK, September 29, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Macy's Inc. (NYSE: M), McKesson Corporation (NYSE: MCK), Best Buy Co. Inc. (NYSE: BBY), United Continental Holdings Inc. (NYSE: UAL) and Pandora Media Inc. (NYSE: P). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6817-100free.

--
Macy's Inc. Research Reports
On September 24, 2014, Macy's Inc.'s (Macy's) stock advanced 1.57% to close the trading session at $59.56, ending the four-day long losing streak. During the session, Macy's stock oscillated in the range of $58.62 - $59.61, with 3.52 million shares changing hands. The stock was 5.61% below its 52-week high of $63.10. Over the past three months, the stock has strengthened 2.69%. The stock closed above its 50-day and 200-day moving averages of $59.17 and $56.67, respectively. The full research reports on Macy's are available to download free of charge at:

http://www.analystsreview.com/Sep-29-2014/M/report.pdf

--
McKesson Corporation Research Reports
On September 22, 2014, McKesson Corporation (McKesson) announced that the Company's Board of Directors has elected Donald R. Knauss and Susan Salka as new Independent Directors, effective October 20, 2014, in a move to enhance its corporate governance. Both Knauss and Salka will become members of the Company's Audit Committee and Governance Committee. The Company informed that Knauss has served as the Chairman and CEO of The Clorox Company since October 2006, while Salka has served as the CEO and President of AMN Healthcare Services, Inc. since 2005. John H. Hammergren, Chairman and CEO, McKesson, said, "Don and Susan are both terrific additions to the McKesson Board. Don will bring strong international business management and retail expertise, while Susan brings a deep understanding of emerging trends in healthcare services." The full research reports on McKesson are available to download free of charge at:

http://www.analystsreview.com/Sep-29-2014/MCK/report.pdf

--
Best Buy Co. Inc. Research Reports
On September 24, 2014, shares in Best Buy Co. Inc. (Best Buy) ended the trading session at $33.99, up 1.89% from its previous day's close of $33.36. Best Buy's stock opened the session at $33.64 and vacillated in the range of $33.43 - $34.11. The stock has a 52-week high of $44.66 and a 52-week low of $22.15. The stock has surged 11.22% in the last three months, as compared to Dow Jones Industrial Average that gained 2.03% over the same period of time. The full research reports on Best Buy are available to download free of charge at:

http://www.analystsreview.com/Sep-29-2014/BBY/report.pdf

--
United Continental Holdings Inc. Research Reports
On September 22, 2014, United Continental Holdings Inc.'s (United Continental) wholly owned subsidiary United Airlines, Inc. (United) informed that it has elected to effect an optional redemption of its remaining outstanding 6% Convertible Junior Subordinated Debentures Due 2030 (Debentures) on October 10, 2014, at a price equal to $50 per $50 principal amount of the Debentures. Upon such redemption, the proceeds will be simultaneously applied to redeem the remaining outstanding Term Income Deferrable Equity Securities (TIDES). United informed that TIDES are convertible into shares of common stock of United Continental. The current conversion price of the TIDES is $57.1429 per share of common stock for each $50 principal amount of Debentures. The holders will retain the right to convert their TIDES into United Continental's common stock until 5:00 pm New York City time on October 9, 2014. The full research reports on United Continental are available to download free of charge at:

http://www.analystsreview.com/Sep-29-2014/UAL/report.pdf

--
Pandora Media Inc. Research Reports
On September 24, 2014, Pandora Media Inc.'s (Pandora) stock moved up 1.64% to close Wednesday's session at $25.46, after oscillating in the range of $24.82 - $25.74. A total of 7.51 million shares were traded during the session, higher than its 30-day average volume of 5.76 million shares. The stock closed below its 50-day and 200-day moving averages of $26.52 and $29.01, respectively. The full research reports on Pandora are available to download free of charge at:

http://www.analystsreview.com/Sep-29-2014/P/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review